Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.



Ultrasound-degradable serum albumin nanoplatform for in situ controlled drug release

Author affiliations

Abstract

In this work, bovine serum albumin-based nanoparticles, BSA-ACVA-DOX NPs, were fabricated for ultrasound-driven drug release, and exhibited excellent tissue penetration. Moreover, a pulsatile release of DOX in vivo could be programmed by in vitro (i.e., remotely) switching the ultrasound on and off.

Graphical abstract: Ultrasound-degradable serum albumin nanoplatform for in situ controlled drug release

Back to tab navigation

Supplementary files

Article information


Submitted
14 Mar 2020
Accepted
20 May 2020
First published
05 Jun 2020

Chem. Commun., 2020, Advance Article
Article type
Communication

Ultrasound-degradable serum albumin nanoplatform for in situ controlled drug release

J. Du, Y. Zhang, H. Ge, C. Shi, S. Long, W. Sun, J. Fan and X. Peng, Chem. Commun., 2020, Advance Article , DOI: 10.1039/D0CC01937B

Social activity

Search articles by author

Spotlight

Advertisements